The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Current Concepts
PreviousPrevious
Volume 357:580-587 August 9, 2007 Number 6
NextNext

Drug-Induced Immune Thrombocytopenia
Richard H. Aster, M.D., and Daniel W. Bougie, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Drug-induced thrombocytopenia can be caused by dozens, perhaps hundreds, of medications. Because thrombocytopenia can have many other causes, the diagnosis of drug-induced thrombocytopenia can easily be overlooked. On occasion, outpatients with drug-induced thrombocytopenia are treated for autoimmune thrombocytopenia and can have two or three recurrences before the drug causing the disorder is identified.1 In acutely ill, hospitalized patients, drug-induced thrombocytopenia can be overlooked because thrombocytopenia is attributed to sepsis, the effect of coronary-artery bypass surgery, or some other underlying condition. Although drug-induced thrombocytopenia is uncommon, it can have devastating, even fatal consequences that can usually be prevented simply by discontinuing . . . [Full Text of this Article]

Presentation

Incidence

Causative Agents

Pathogenesis

Thrombocytopenia Induced by Quinine and Other Drugs

Thrombocytopenia Induced by Platelet Inhibitors

Thrombocytopenia Induced by Abciximab

Thrombocytopenia Due to Drug-Induced Autoantibodies

Diagnosis

Treatment and Prognosis


Source Information

From the Department of Medicine, Medical College of Wisconsin (R.H.A.), and the Blood Research Institute, BloodCenter of Wisconsin (R.H.A., D.W.B.) — both in Milwaukee.

Address reprint requests to Dr. Aster at the Blood Research Institute, BloodCenter of Wisconsin, 8727 Watertown Plank Rd., Milwaukee, WI 53226-3548, or at richard.aster@bcw.edu.


Related Letters:

Drug-Induced Immune Thrombocytopenia
Naina H. V.K., Harris S., Matzdorff A. C., Cathomas R., Goldhirsch A., von Moos R., Aster R. H., Bougie D. W.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:1869-1871, Nov 1, 2007. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.